Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine
NYSE: JNJ $173.13 -$0.53 (0.000%)
- Day High $174.49
- Day Low $172.48
- Volume 7,106,790
Last Updated: 8/31/2021 04.10 PM
Save the Date: 2021 Business Review
Our business review focused on the Pharmaceuticals Sector will be held on November 18, 2021. Please save the date, and check back here for more details to follow.
Latest News Releases
August 26, 2021
August 25, 2021
August 24, 2021
See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Effective management of ESG matters is a business imperative.
Contact Investor Relations
Questions? Please contact Investor Relations:
Tell us about you
Find us at the office
Eastmond- Sukel street no. 62, 79540 Hanga Roa, Easter Island
Give us a ring
+74 201 709 645
Mon - Fri, 9:00-15:00